Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Scully’s Successor Awaited By Device Reps: Will Improved Access Continue?

This article was originally published in The Gray Sheet

Executive Summary

Retaining access to top-level CMS officials is a primary objective of device stakeholders following the imminent departure of Administrator Tom Scully

You may also be interested in...

Power Wheelchairs Targeted For Inherent Reasonableness Price Adjustments

CMS plans to develop inherent reasonableness review guidelines to ensure appropriate Medicare payments for motorized wheelchairs as part of a larger initiative to curb provider billing fraud, the agency says

CMS May Use Med-Tech Council To Address Small Company Concerns

The Centers for Medicare & Medicaid Services is urging small manufacturers to provide examples of new technology dissemination being stifled due to inadequate reimbursement

CMS To Meet With NASPE/HRS, Manufacturers To Review ICD Decision Process

Guidant maintains that its MADIT-II trial ethically could not have been extended to provide more evidence of the long-term benefits of ICDs for the entire study population

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts